NasdaqGM:TVTXBiotechs
Why Everyone Is Watching Travere Therapeutics (TVTX) Today
Travere Therapeutics (TVTX) is back in focus after being named IBD Stock Of The Day, with recent coverage centering on progress for its kidney disease treatment Filspari and the resulting pickup in investor attention.
See our latest analysis for Travere Therapeutics.
At a share price of $65.71, Travere Therapeutics has seen strong momentum recently, with a 30 day share price return of 16.8% and a 1 year total shareholder return of 266.69%, suggesting that investors are reassessing both growth...